PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 17, 2014, Pages 6383-6388

  Aslam, M Imran ^a,b,c   Abraham, Jinu ^a   Mansoor, Atiya ^b   Druker, Brian J ^a,b,c   Tyner, Jeffrey W ^a   Keller, Charles ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Muscle; Pediatric; Sarcoma

Indexed keywords

DASATINIB; EPHRIN RECEPTOR B4; IMATINIB; LIGAND; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CELL VIABILITY; COLONY FORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; GENE SILENCING; HUMAN; IMMUNOHISTOCHEMISTRY; INTERNAL RIBOSOME ENTRY SITE; LUNG METASTASIS; MOUSE; MTS ASSAY; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RHABDOMYOSARCOMA; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR CELL;

MUSCLE; PEDIATRIC; SARCOMA;

ANIMALS; APOPTOSIS; BENZAMIDES; CELL ADHESION; CELL PROLIFERATION; CELL SURVIVAL; EPHRIN-B2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MICE; PAIRED BOX TRANSCRIPTION FACTORS; PHOSPHORYLATION; PIPERAZINES; PROGNOSIS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-SIS; PYRIMIDINES; RECEPTOR CROSS-TALK; RECEPTOR, EPHB4; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RHABDOMYOSARCOMA, ALVEOLAR; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; THIAZOLES;

EID: 84899650764     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1403608111     Document Type: Article

References (31)

1. Arndt CA, Crist WM (1999) Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341(5):342-352.
2. Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A (2009) Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: An analysis of 2,600 patients. J Clin Oncol 27(20):3391-3397.
3. Blandford MC, et al. (2006) Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: A report from the Children's Oncology Group. Pediatr Blood Cancer 46(3):329-338.
4. Xia G, et al. (2006) EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene 25(5):769-780.
5. Oricchio E, et al. (2011) The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell 147(3):554-564.
6. Noren NK, Foos G, Hauser CA, Pasquale EB (2006) The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol 8(8):815-825.
7. Kumar SR, et al. (2009) Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res 69(9):3736-3745.
8. Kertesz N, et al. (2006) The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth. Blood 107(6):2330-2338.
9. Miao H, et al. (2009) EphA2 mediates ligand-dependent inhibition and ligandindependent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 16(1):9-20.
10. Leroy C, et al. (2009) Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells. Cancer Res 69(6):2279-2286.
11. Batlle E, et al. (2005) EphB receptor activity suppresses colorectal cancer progression. Nature 435(7045):1126-1130.
12. Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22(10):1276-1312.
13. Ostman A, Heldin CH (2007) PDGF receptors as targets in tumor treatment. Adv Cancer Res 97:247-274.
14. Steller EJ, et al. (2013) PDGFRB promotes liver metastasis formation of mesenchymallike colorectal tumor cells. Neoplasia 15(2):204-217.
15. Noel P, Mesa RA (2013) Eosinophilic myeloid neoplasms. Curr Opin Hematol 20(2): 157-162.
16. Heinrich MC, et al. (2003) PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299(5607):708-710.
17. Taniguchi E, et al. (2008) PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma. Oncogene 27(51):6550-6560.
18. He S, et al. (2010) Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro. Invest Ophthalmol Vis Sci 51(1):543-552.
19. Hawkins DS, Spunt SL, Skapek SX; COG Soft Tissue Sarcoma Committee (2013) Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas. Pediatr Blood Cancer 60(6):1001-1008.
20. Nishijo K, et al. (2009) Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma. Cancer Res 69(7):2902-2911.
21. Keller C, et al. (2004) Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: Cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev 18(21):2614-2626.
22. Tyner JW, et al. (2008) RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia. Blood 111(4):2238-2245.
23. Tyner JW, et al. (2009) RNAi screen for rapid therapeutic target identification in leukemia patients. Proc Natl Acad Sci USA 106(21):8695-8700.
24. Ginsberg JP, Davis RJ, Bennicelli JL, Nauta LE, Barr FG (1998) Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma. Cancer Res 58(16):3542-3546.
25. Wang Q, Kumar S, Mitsios N, Slevin M, Kumar P (2007) Investigation of downstream target genes of PAX3c, PAX3e and PAX3g isoforms in melanocytes by microarray analysis. Int J Cancer 120(6):1223-1231.
26. Cao L, et al. (2010) Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res 70(16):6497-6508.
27. Masood R, et al. (2006) EphB4 provides survival advantage to squamous cell carcinoma of the head and neck. Int J Cancer 119(6):1236-1248.
28. Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB (2004) Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc Natl Acad Sci USA 101(15):5583-5588.
29. Cen L, et al. (2007) Phosphorylation profiles of protein kinases in alveolar and embryonal rhabdomyosarcoma. Mod Pathol 20(9):936-946.
30. Armistead PM, et al. (2007) Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: Correlation with overall survival in 105 patients. Cancer 110(10):2293-2303.
31. Johnson FM, et al. (2010) Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors. Cancer 116(6):1582-1591.